Effect of Osteopathic Manipulative Treatment on Reduction of Pain in Complicated Newborns: RCT
Not Applicable
- Conditions
- Prematurity
- Interventions
- Other: usual careOther: sham therapyOther: osteopathic manipulative treatment
- Registration Number
- NCT02146690
- Lead Sponsor
- European Institute for Evidence Based Osteopathic Medicine
- Brief Summary
The aim of the present 3 armed placebo control parallel group randomized control trial is to explore the extent to which osteopathic manipulative treatment is effective in reducing pain in a population of complicated newborns.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 225
Inclusion Criteria
- newborns born in the same hospital
- either gender
- diagnosis of any pathological/clinical medical condition
Exclusion Criteria
- lack of guardian consent
- newborn transferred to/from other hospital
- lack of any of the inclusion criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description usual care usual care newborns allocated in the usual care arm will receive standard care only sham sham therapy newborns will receive sham treatment for the entire period of hospitalization plus usual care osteopathic manipulative treatment osteopathic manipulative treatment newborns will receive osteopathic manipulative evaluation and treatment during the entire period of hospitalization plus usual care osteopathic manipulative treatment usual care newborns will receive osteopathic manipulative evaluation and treatment during the entire period of hospitalization plus usual care sham usual care newborns will receive sham treatment for the entire period of hospitalization plus usual care
- Primary Outcome Measures
Name Time Method baseline changes in pain score using Premature Infant Pain Profile baseline and end of hospitalization, expected hospitalization 4 weeks
- Secondary Outcome Measures
Name Time Method Length of stay in days participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Trial Locations
- Locations (1)
Pescara Civil Hospital
🇮🇹Pescara, Italy